Cyclo Therapeutics, Inc. (CYTH) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 1 Buy, 2 Hold.
The consensus price target is $0.95, representing an upside of 31.8% from the current price $0.72.
CYTH Stock — 12-Month Price Forecast
$0.95
▲ +31.83% Upside
Average Price Target
Based on 3 Wall Street analysts offering 12-month price targets for Cyclo Therapeutics, Inc., the price target is $0.95.
The average price target represents a +31.83% change from the last price of $0.72.
CYTH Analyst Ratings
Hold
Based on 3 analysts giving stock ratings to Cyclo Therapeutics, Inc. in the past 3 months
